By contrast, intrathecal administration of finasteride (150 nmol in combination with progesterone) from days 0 to 1 post-surgery had no effect on the progesterone-induced enhancement of GFAP-immunoreactivity during the induction phase of CCI-induced neuropathy (Figures 3A, B; **p < 0.01 vs. VEH-treated CCI group). Here, GFAP is linked to neuropathy.